| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2020 | Ryan Thomas F Jr66 | Director | Sale+OE | 1,000 | $91.48 | $91,480.00 | -34.2% | |
| Mar 4, 2020 | Cox John | Director | Sale+OE | 10,000 | $93.39 | $933,900.00 | -78.2% | |
| Mar 4, 2020 | Snodgres Jon59 | Chief Financial Officer | Sell | 1,655 | $89.58 | $148,247.35 | -2.2% | |
| Mar 4, 2020 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 3,005 | $90.40 | $271,645.45 | -3.5% | |
| Mar 4, 2020 | Ryan Thomas F Jr66 | Director | Sale+OE | 7,021 | $87.84 | $616,707.72 | -64.6% | |
| Mar 4, 2020 | Hunt Anthony75 | Chief Executive Officer | Sell | 14,490 | $89.84 | $1,301,793.00 | -2.0% | |
| Feb 26, 2020 | Snodgres Jon59 | Chief Financial Officer | Sell | 1,100 | $86.22 | $94,836.50 | -1.7% | |
| Feb 26, 2020 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 195 | $86.60 | $16,887.00 | -0.7% | |
| Feb 26, 2020 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 15,210 | $90.41 | $1,375,073.92 | -1.3% | |
| Feb 24, 2020 | Cox John | Director | Sell | 4,455 | $92.81 | $413,454.80 | -31.0% |